Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

71.00
Delayed Data
As of Feb 05
 -1.03 / -1.43%
Today’s Change
64.51
Today|||52-Week Range
133.62
-34.53%
Year-to-Date

Today’s Trading

Previous close72.03
Today’s open70.68
Day’s range68.00 - 71.56
Volume4,473,463
Average volume (3 months)2,116,864
Market cap$13.2B
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+31.10%
Earnings growth (next 5 years)+199.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-0.43-0.79%
BMRNBiomarin Pharmaceuti...-2.74-3.85%
MNKMallinckrodt Plc+0.68+0.99%
RDYDr.Reddy's Laborator...+0.30+0.67%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateFebruary 11, 2016
EPS forecast (this quarter)$0.09
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers